Phospho-Akt overexpression is prognostic and can be used to tailor the synergistic interaction of Akt inhibitors with gemcitabine in pancreatic cancerDaniela Massihnia, Elisa Giovannetti|Journal of Hematology & Oncology|2017Cited by 84